MessageFrom: French, Elizabeth Sent: Wednesday, October 22, 2003 2:21 PM To: Butler, Jennie C Subject: FW: Comments re: the FDA's Drug AntiCounterfeiting Initiative: Multi-Stable Isotope Analysis -----Original Message----- From: Bernstein, Ilisa Sent: Wednesday, October 22, 2003 1:02 PM To: French, Elizabeth Subject: FW: Comments re: the FDA's Drug AntiCounterfeiting Initiative: Multi-Stable Isotope Analysis Elizabeth, Can you please send this on to DOCKETS be placed in the counterfeit drug initiative docket (2003N-0361). Thanks. ilisa -----Original Message----- From: John P. Jasper [mailto:JPJasper@MolecularIsotopes.com] Sent: Tuesday, October 21, 2003 7:41 PM To: Ilisa Bernstein Subject: Comments re: the FDA's Drug AntiCounterfeiting Initiative: Multi-Stable Isotope Analysis Dear Dr./Esq. Bernstein: Attached please find an electronic version of my Comments regarding the forensic technique of Multi-Stable Isotopic Analysis for the FDA's Drug Anticounterfeiting Initiative (Docket No. 2003N-0361). A hard copy of those comments will arrive posthaste by courier. The Comments are in three parts: 1. A letter ("FDAacdiIB"); 2. A preprint of a J. Pharm. Biomed. Anal. paper, jointly produced by members of the FDA's CDER and Molecular Isotope Technologies (As a preprint, it is presented in four parts, all with the prefix "JPBA"); and, 3. Two brochures regarding commercial instrumentation used in Multi-Stable Isotopic Analysis (which can be accessed thorough the websites noted in the letter.) Please feel free forward any questions regarding Multi-Stable Isotopic Analysis of pharmaceutical components to me. Respectfully Yours, John Jasper ----------------------------------------------------------------------------- Dr. John P. Jasper, Chief Scientific Officer Molecular Isotope Technologies, LLC 8 Old Oak Lane, Niantic, CT 06357 USA (860) 739-1926 (Office) (860) 739-3250, then *51 (Fax) (Internet) (Website) Time: ET(US) = GMT + 5